ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 134 filers reported holding ITEOS THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $14,304,291 | +81.6% | 963,901 | +66.9% | 0.00% | – |
Q1 2024 | $7,877,714 | +30.4% | 577,545 | +4.7% | 0.00% | – |
Q4 2023 | $6,039,527 | -65.1% | 551,555 | -65.1% | 0.00% | -100.0% |
Q3 2023 | $17,317,348 | -16.4% | 1,581,493 | +1.0% | 0.00% | 0.0% |
Q2 2023 | $20,723,274 | -16.7% | 1,565,202 | -14.3% | 0.00% | 0.0% |
Q1 2023 | $24,870,792 | -63.3% | 1,827,391 | -47.4% | 0.00% | -50.0% |
Q4 2022 | $67,858,548 | +69.0% | 3,474,580 | +64.8% | 0.00% | -33.3% |
Q3 2022 | $40,155,000 | -21.3% | 2,107,868 | -14.9% | 0.00% | 0.0% |
Q2 2022 | $51,054,000 | -7.3% | 2,478,332 | +44.8% | 0.00% | 0.0% |
Q1 2022 | $55,089,000 | +55.0% | 1,711,891 | +124.3% | 0.00% | +50.0% |
Q4 2021 | $35,542,000 | +308.7% | 763,351 | +137.0% | 0.00% | – |
Q3 2021 | $8,697,000 | +6.6% | 322,107 | +1.2% | 0.00% | – |
Q2 2021 | $8,161,000 | -66.0% | 318,169 | -54.7% | 0.00% | -100.0% |
Q1 2021 | $24,029,000 | +275.9% | 703,010 | +272.0% | 0.00% | – |
Q4 2020 | $6,392,000 | +97.5% | 189,002 | +44.0% | 0.00% | – |
Q3 2020 | $3,237,000 | – | 131,229 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |